Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-055890
Filing Date
2017-09-06
Accepted
2017-09-06 20:41:14
Documents
1
Period of Report
2017-09-02

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6044
  Complete submission text file 0001104659-17-055890.txt   7685
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 171072560